Track topics on Twitter Track topics that are important to you
Boston Scientific Corp. agreed to buy private urology device firm NxThera Inc. for up to $406mm. Through its participation in NxThera's December 2015 Series D round, BSC already has an undisclosed min...
The acquisition of NxThera, maker of the minimally invasive Rezum system to treat symptomatic benign prostatic hyperplasia, w -More-
Boston Scientific entered a deal to buy NxThera, which makes the Rezum system for treating symptomatic enlarged prostate, for -More-
MARLBOROUGH, Mass., April 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the Rezūm® system, a mini...
Medical technology firm Boston Scientific has agreed to acquire US-based privately-held firm NxThera in a transaction worth $406m.
Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia MARLBOROUGH, Mass., March 21, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX...
The Rezūm Center of Excellence program recognizes distinguished urologists across the country for their outstanding care of men suffering from lower urinary tract symptoms caused by BPH, and their ac...
Acquisitions and product development updates galore, in this week's Medical Device Reading List!Stryker wins Deal of the Year for buying NovadaqDemitri Diakantonis, The Middle Market ($SYK)Medtronic (...
Evaluate the effect of the NxThera BPH Rezum System on prostate tissue in subjects suffering from LUTS symptoms secondary to benign prostatic hyperplasia (BPH).
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The Companyâs RezÅ«m System delivers vapor directly to the prostate to re...
NxThera is pioneering the application of its sterile water vapor technology platform in a variety of endourology conditions including BPH, prostate cancer and kidney cancer. NxThe...
We have published hundreds of NxThera news stories on BioPortfolio along with dozens of NxThera Clinical Trials and PubMed Articles about NxThera for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NxThera Companies in our database. You can also find out about relevant NxThera Drugs and Medications on this site too.
Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...